ArticleJournal of clinical and experimental hematopathology : JCEH2024

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma.

Tatsuo Oyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.